Skip to main content

Market Overview

Trade RMED stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
5/14/20Piper SandlerMaintainsNeutral1.0
3/11/20Cantor FitzgeraldMaintainsNeutral1.5
8/13/19Piper JaffrayDowngradesOverweightNeutral1.5

Earnings View Earnings

Q3 2020 EST Actual Surprise
EPS: -0.130 -0.130 0.0000
Rev: 1.08M 914.00K -166.00K
Q4 2020 EST Actual Surprise
EPS: Expected